Skip to content

Bn'ML – Behavioral & Molecular Lab

Portuguese preclinical CRO providing customized behavioral and molecular analysis services using rodent models of disease.

Last updated September 29, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Bn'ML – Behavioral & Molecular Lab is a Portuguese contract research organization (CRO) based in the Braga Campus of the University of Minho. The company works in close association with the Life and Health Sciences Research Institute (ICVS), a biomedical and clinical sciences research institute linked to a network of hospitals, biomedical companies and the Clinical Academic Center. Bn'ML provides customized preclinical behavioral and molecular analysis services using rodent animal models, for testing the potential of new therapeutic compounds. Its rodent models of disease are pre-validated and have been calibrated using appropriate experimental controls. The company's mission is to optimize the sorting process of therapeutic compounds in a preclinical phase, sustaining the investment associated with the transition to a later clinical-trials phase. Bn'ML tests the potential of therapeutic compounds, both at the behavioral and molecular levels, in animal models of disease, thus adding an extra dimension to the preclinical tests phase. In this way, the company allows a comprehensive evaluation of the therapeutic compounds effects, sustaining the investment associated to the transition to a clinical trials phase. Bn'ML services include a flexible design of the study to evaluate the therapeutic potential of new compounds, according to customer's requirements; the induction of the disease symptoms in animals; the administration of the compounds in animals; the evaluation of the therapeutic potential of the compounds at the behavioral and molecular levels; and the preparation of a final report with interpretative analysis of the results and study conclusions, to be delivered to the customer. In addition to the behavioral and molecular analysis services for assessing the therapeutic potential of new compounds, Bn'ML provides scientific advice within the development of new therapeutic solutions. Bn'ML cooperates actively with several scientific partners, thus benefiting from an extensive set of technical resources to better meet its customers' needs. Bn'ML intends to be an essential partner of the international pharmaceutical industry, in the preclinical phase of development and validation of new therapeutic compounds. For that, the company is building up its strategy in the expertise of a multidisciplinary team specialized in cutting-edge techniques. The company has received recognition including the 1st Award at the SpinUM Business Ideas Contest 2011 (TecMinho), the SpinUM Young Entrepreneurs Prize 2011 (TecMinho), and the 13th Edition of the Young Entrepreneur Award 2013 sponsored by ANJE.

History

Bn'ML – Behavioral & Molecular Lab is a Portuguese contract research organization (CRO) based in the Braga Campus of the University of Minho. The company works in close association with the Life and Health Sciences Research Institute (ICVS), a biomedical and clinical sciences research institute linked to a network of hospitals, biomedical companies and the Clinical Academic Center. Bn'ML provides customized preclinical behavioral and molecular analysis services using rodent animal models, for testing the potential of new therapeutic compounds. Its rodent models of disease are pre-validated and have been calibrated using appropriate experimental controls. The company's mission is to optimize the sorting process of therapeutic compounds in a preclinical phase, sustaining the investment associated with the transition to a later clinical-trials phase. Bn'ML tests the potential of therapeutic compounds, both at the behavioral and molecular levels, in animal models of disease, thus adding an extra dimension to the preclinical tests phase. In this way, the company allows a comprehensive evaluation of the therapeutic compounds effects, sustaining the investment associated to the transition to a clinical trials phase. Bn'ML services include a flexible design of the study to evaluate the therapeutic potential of new compounds, according to customer's requirements; the induction of the disease symptoms in animals; the administration of the compounds in animals; the evaluation of the therapeutic potential of the compounds at the behavioral and molecular levels; and the preparation of a final report with interpretative analysis of the results and study conclusions, to be delivered to the customer. In addition to the behavioral and molecular analysis services for assessing the therapeutic potential of new compounds, Bn'ML provides scientific advice within the development of new therapeutic solutions. Bn'ML cooperates actively with several scientific partners, thus benefiting from an extensive set of technical resources to better meet its customers' needs. Bn'ML intends to be an essential partner of the international pharmaceutical industry, in the preclinical phase of development and validation of new therapeutic compounds. For that, the company is building up its strategy in the expertise of a multidisciplinary team specialized in cutting-edge techniques. The company has received recognition including the 1st Award at the SpinUM Business Ideas Contest 2011 (TecMinho), the SpinUM Young Entrepreneurs Prize 2011 (TecMinho), and the 13th Edition of the Young Entrepreneur Award 2013 sponsored by ANJE.

  • 1st Award - SpinUM Business Ideas Contest 2011, TecMinho

  • SpinUM Young Entrepreneurs Prize 2011, TecMinho

  • 13th Edition of the Young Entrepreneur Award 2013, ANJE

Products and positioning

A preclinical CRO that adds behavioral and molecular dimensions to compound testing, aiming to be an essential partner of the international pharmaceutical industry in the preclinical phase.

  • Preclinical behavioral analysis

    Evaluation of therapeutic compounds at the behavioral level in rodent models of disease.

  • Preclinical molecular analysis

    Evaluation of therapeutic compounds at the molecular level in rodent models of disease.

  • Custom study design

    Flexible design of studies to evaluate the therapeutic potential of new compounds according to customer requirements.

  • Scientific advice

    Scientific advice within the development of new therapeutic solutions.

Sources5 sources

Cite this profile: Cite the canonical profile. /brand-wiki/behavioral-and-molecular-lab-portugal · Editorial policy · How profiles are compiled